Indeed, a large body of evidence supports the notion that NRF2 overactivation is strictly associated with tumor invasiveness, distant metastasis formation, therapy resistance, and poor clinical outcomes in many cancer patients [6]. Here, NFE2L2 is linked to neoplasm.